Mounjaro, a novel medication for managing type 2 diabetes and occasionally obesity, has generated significant interest in the UK. At present, availability is restricted primarily through private pharmacy services. The expense of Mounjaro can be substantial, typically ranging from around £60 to £600 per month, depending on the strength and supplie